Profile data is unavailable for this security.
About the company
Svas Biosana SpA is an Italy-based company engaged in manufacturing and distribution of medical devices. The Company has two core businesses, namely industrial core and sales core. Industrial core focuses on production and marketing of medical devices, consisting of Farmex and Medical business lines. Sales core is dedicated to trading and distribution of medical devices, consisting of the SVAS and Mark Medical business lines. Farmex is focused on the production and sale of incontinence aids, traditional dressings, cotton wool and products for personal care. Medical business line focuses on production and sale of operating packs, medical devices for infusion and aspiration, linen, advanced dressings and lubricating gel for urology. SVAS is dedicated to selling specialist medical devices for medicine and surgery. Mark Medical is focused on selling medical devices. The Company operates globally.
- Revenue in EUR (TTM)132.55m
- Net income in EUR6.74m
- Incorporated1992
- Employees350.00
- LocationSvas Biosana SpAVia Trentola, 7SOMMA VESUVIANA 80046ItalyITA
- Websitehttp://www.svas.it/
More ▼
Mergers & acquisitions
| Acquired company | SVS:MIL since announced | Transaction value |
|---|---|---|
| Mehos SRL | 13.59% | 1.05m |
Data delayed at least 15 minutes, as of Feb 10 2026 16:35 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mentice AB | 25.82m | -4.07m | 36.12m | 121.00 | -- | 3.05 | -- | 1.40 | -1.68 | -1.68 | 10.52 | 4.48 | 0.9663 | 1.60 | 3.94 | 2,095,328.00 | -15.25 | -6.64 | -31.60 | -11.91 | 90.40 | 84.80 | -15.78 | -8.53 | 0.845 | -30.10 | 0.116 | -- | 6.11 | 14.22 | -553.89 | -- | 32.86 | -- |
| Substrate Artificial Inteligence SA | 18.71m | 7.57m | 37.43m | 27.00 | 0.7102 | 0.1827 | 4.30 | 2.00 | 0.0958 | 0.0958 | 0.1972 | 0.3722 | 0.3196 | 1.52 | 3.88 | 693,097.80 | 12.30 | -- | 17.59 | -- | 86.07 | -- | 38.49 | -- | 0.6249 | 3.83 | 0.0919 | -- | 103.54 | -- | 183.37 | -- | -- | -- |
| Theraclion SA | 1.90m | -5.25m | 39.80m | 33.00 | -- | -- | -- | 20.92 | -0.1127 | -0.1127 | 0.0408 | -0.0548 | 0.1479 | 0.3304 | 8.74 | 59,455.31 | -40.84 | -33.44 | -55.80 | -47.33 | 54.01 | 66.95 | -276.15 | -360.91 | 1.79 | -67.33 | 2.50 | -- | -54.44 | -21.49 | -56.66 | -- | -4.97 | -- |
| Ortoma AB | 7.26m | -707.29k | 42.98m | 10.00 | -- | 2.90 | 87.50 | 5.92 | -0.2027 | -0.2027 | 2.08 | 4.45 | 0.4243 | 3.95 | 39.13 | 7,530,537.00 | -4.13 | -9.37 | -4.45 | -10.43 | 41.26 | 158.24 | -9.74 | -78.90 | 3.02 | -- | 0.00 | -- | 28.77 | -- | 46.83 | -- | -0.5751 | -- |
| Q linea AB | 1.04m | -17.17m | 43.51m | 83.00 | -- | 1.37 | -- | 41.68 | -35.87 | -35.87 | 1.31 | 17.84 | 0.0429 | 0.4006 | 2.90 | -- | -70.50 | -76.00 | -101.81 | -93.84 | -15.26 | -145.47 | -1,644.30 | -2,820.51 | 10.04 | -30.48 | 0.017 | -- | 369.86 | 114.75 | 15.86 | -- | -34.47 | -- |
| MeVis Medical Solutions AG | 16.06m | 3.17m | 44.05m | 102.00 | 14.03 | 2.49 | 13.30 | 2.74 | 1.74 | 1.74 | 8.82 | 9.79 | 0.6134 | -- | 8.55 | 157,463.40 | 12.09 | 17.83 | 15.71 | 24.04 | 97.70 | 97.09 | 19.71 | 29.27 | -- | -- | 0.00 | 34.61 | -5.36 | -1.28 | -30.58 | -11.11 | 6.49 | 0.00 |
| Bactiguard Holding AB | 21.52m | -737.91k | 46.58m | 153.00 | -- | 1.77 | 12.62 | 2.16 | -0.2238 | -0.2238 | 6.53 | 8.99 | 0.381 | 3.44 | 6.91 | 1,495,216.00 | -1.31 | -8.02 | -1.86 | -10.13 | 63.78 | 48.56 | -3.43 | -25.10 | 1.38 | -0.3387 | 0.3410 | -- | -12.64 | 4.22 | 73.69 | -- | -17.92 | -- |
| Modulight Oyj | 6.76m | -4.61m | 48.67m | 71.00 | -- | 1.07 | -- | 7.20 | -0.1172 | -0.1172 | 0.1727 | 1.07 | 0.1254 | -0.7943 | 4.78 | 102,484.90 | -8.55 | -9.90 | -9.25 | -10.66 | 129.94 | 119.43 | -68.15 | -88.50 | 3.46 | -- | 0.081 | -- | 1.74 | -10.65 | 45.65 | -- | 24.38 | -- |
| Svas Biosana SpA | 132.55m | 6.74m | 49.73m | 350.00 | 6.99 | 0.7271 | 3.93 | 0.3752 | 1.27 | 1.27 | 24.96 | 12.21 | 0.7835 | 2.88 | 2.55 | 405,363.60 | 3.99 | 2.94 | 6.57 | 4.91 | 26.17 | 27.37 | 5.09 | 4.11 | 1.34 | 4.75 | 0.5304 | -- | 1.72 | 10.34 | 14.68 | 18.79 | 10.25 | -- |
| Aoti Inc | 53.61m | 1.98m | 51.03m | 80.00 | 21.19 | 3.43 | 12.95 | 0.9519 | 0.0197 | 0.0197 | 0.4687 | 0.1219 | 1.32 | 2.17 | 4.65 | -- | 4.87 | -- | 6.54 | -- | 88.13 | -- | 3.69 | -- | 2.54 | 2.81 | 0.5269 | -- | 32.88 | -- | 78.55 | -- | -- | -- |
| Ondine Biomedical Inc | 1.36m | -14.80m | 53.79m | 43.00 | -- | 102.33 | -- | 39.42 | -0.0353 | -0.0353 | 0.0032 | 0.0009 | 0.3447 | 0.5771 | 8.03 | -- | -373.83 | -- | -4,807.85 | -- | 65.77 | -- | -1,084.66 | -- | 0.7948 | -- | 0.4333 | -- | 70.32 | -- | -32.51 | -- | -- | -- |
| EasyMotionSkin Tec GmbH | -100.00bn | -100.00bn | 53.83m | 17.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 229.95 | -- | -214.79 | -- | -- | -- |
| AbL Diagnostics SA | 5.45m | 463.37k | 55.43m | 20.00 | 119.53 | 7.98 | 46.03 | 10.17 | 0.0288 | 0.0288 | 0.3383 | 0.4308 | 0.4416 | -- | 1.60 | 286,763.20 | 3.76 | 3.59 | 5.34 | 5.29 | -- | -- | 8.50 | 8.20 | 2.91 | -- | 0.2788 | -- | -5.03 | -- | 424.60 | -- | -- | -- |
| Nanexa AB | 994.92k | -3.67m | 56.59m | 15.00 | -- | 7.50 | -- | 56.88 | -0.2644 | -0.2644 | 0.0694 | 0.4874 | 0.0972 | 24.67 | 1.54 | 813,538.40 | -35.91 | -37.21 | -42.59 | -44.95 | 69.56 | 93.79 | -369.29 | -355.05 | 2.07 | -21.98 | 0.2165 | -- | -16.93 | 70.11 | 67.40 | -- | 21.42 | -- |
| Fonet Bilgi Teknolojileri AS | 11.87m | 3.18m | 59.11m | 504.00 | 18.60 | 2.03 | 10.23 | 4.98 | 0.1764 | 0.1764 | 0.6584 | 1.61 | 0.4074 | 20.98 | 6.79 | 1,203,616.00 | 10.91 | 16.47 | 11.48 | 18.25 | 30.30 | 31.60 | 26.79 | 36.96 | 1.53 | -- | 0.0177 | 0.00 | 33.24 | 57.81 | -30.02 | 59.29 | 67.65 | -- |
Data as of Feb 10 2026. Currency figures normalised to Svas Biosana SpA's reporting currency: Euro EUR
9.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Kairos Partners SGR SpAas of 30 Jun 2025 | 291.59k | 5.21% |
| AcomeA SGR SpAas of 30 Jun 2025 | 112.00k | 2.00% |
| CARTHESIO SAas of 30 Jun 2025 | 60.00k | 1.07% |
| Sumus Capital SAas of 31 Dec 2025 | 16.00k | 0.29% |
| Banca Finnat Euramerica SpA (Investment Management)as of 30 Sep 2025 | 15.14k | 0.27% |
| Sella SGR SpAas of 30 Jan 2026 | 10.91k | 0.20% |
| Banca del Sempione SAas of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
